risk of glp 1 for weight loss GLP-1 Drugs and Eating Disorders: A Hidden in the Revolution – The Chicago Council on Science and Technology Myths & Facts: GLP-1 Drugs

GLP-1 receptor agonists have demonstrated substantial benefits in managing type 2 diabetes and obesity, including improved blood sugar control , weight reduction, and lower cardiovascular risk in appropriate patients

The results of Pleiotropy, MR-Egger and MR-PRESSO showed that there were no horizontal pleiotropy (P were all greater than 0.05)

On the other hand, when the drug is injected at tissues with high FCD, relatively faster single-shot injection is recommended for spreading the drug widely in horizontal direction to cover as many capillaries as possible

doi: 10.1016/j.bpg.2025.102064 96 IsmailYLeeHRiordanSMGrimmMCZhangL

Acute exposure to indole stimulated basolateral secretion of GLP-1 from rat colonic tissue, which is likely to be mediated through direct activation of L-cells by indole (Chimerel et al., 2014) but could also be through indirect mechanisms

There is currently no definitive evidence establishing that one GLP-1 receptor agonist is superior to another specifically for anti-inflammatory effects